DS
ASTH icon

David Shaw’s Astrana Health ASTH Stock Holding History

David Shaw’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-145,556
Closed -$4.13M – 5087
2025
Q3 		$4.13M Buy
+145,556
New +$3.94M ﹤0.01% 2378
2021
Q2 		– Sell
-19,019
Closed -$515K – 5066
2021
Q1 		$515K Buy
19,019
+7,430
+64% +$179K ﹤0.01% 3487
2020
Q4 		$212K Buy
+11,589
New +$208K ﹤0.01% 3717

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

David Shaw's ASTH Position: Q4 2025 in Review

David Shaw sold out of Astrana Health (ASTH) in Q4 2025, closing a stake of 145,556 shares — an estimated $4.13M sold.

David Shaw first reported a position in ASTH in Q4 2020 and held it in 3 quarters. The position peaked at $4.13M in Q3 2025. 175 funds tracked by Wall St. Rank hold ASTH as of Q4 2025.

  • David Shaw reported no remaining Astrana Health position as of Q4 2025 after selling out during the quarter.
  • David Shaw sold 145,556 Astrana Health shares in Q4 2025, an estimated $4.13M.
  • David Shaw first reported a position in Astrana Health in Q4 2020 and held it in 3 quarters.
  • David Shaw's Astrana Health position peaked at $4.13M in Q3 2025.
  • 175 funds tracked by Wall St. Rank held Astrana Health as of Q4 2025.

Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.